Notification of Change of Registered Office Address

ImmuPharma PLC (LSE:IMM), (Euronext Growth Brussels: ALIMM), the specialist drug discovery and development company announces that with immediate effect, its registered office address has been changed to: One Bartholomew Close, London, EC1A 7BL.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (“MAR”).